434 related articles for article (PubMed ID: 25850214)
21. Preparation and characterization of inclusion complexes formed between baicalein and cyclodextrins.
Zhou Q; Wei X; Dou W; Chou G; Wang Z
Carbohydr Polym; 2013 Jun; 95(2):733-9. PubMed ID: 23648035
[TBL] [Abstract][Full Text] [Related]
22. Ternary system of dihydroartemisinin with hydroxypropyl-β-cyclodextrin and lecithin: simultaneous enhancement of drug solubility and stability in aqueous solutions.
Wang D; Li H; Gu J; Guo T; Yang S; Guo Z; Zhang X; Zhu W; Zhang J
J Pharm Biomed Anal; 2013 Sep; 83():141-8. PubMed ID: 23732534
[TBL] [Abstract][Full Text] [Related]
23. Investigations of bisacodyl with modified β-cyclodextrins: Characterization, molecular modeling, and effect of PEG.
Li S; Wang L; Jiang J; Tang P; Wang Q; Wu D; Li H
Carbohydr Polym; 2015 Dec; 134():82-91. PubMed ID: 26428103
[TBL] [Abstract][Full Text] [Related]
24. Solid state studies of drug-cyclodextrin inclusion complexes in PEG 6000 prepared by a new method.
Wulff M; Aldén M
Eur J Pharm Sci; 1999 Aug; 8(4):269-81. PubMed ID: 10425377
[TBL] [Abstract][Full Text] [Related]
25. Self-assembly of cyclodextrin complexes: aggregation of hydrocortisone/cyclodextrin complexes.
Messner M; Kurkov SV; Brewster ME; Jansook P; Loftsson T
Int J Pharm; 2011 Apr; 407(1-2):174-83. PubMed ID: 21237259
[TBL] [Abstract][Full Text] [Related]
26. Study of freeze-dried quercetin-cyclodextrin binary systems by DSC, FT-IR, X-ray diffraction and SEM analysis.
Pralhad T; Rajendrakumar K
J Pharm Biomed Anal; 2004 Feb; 34(2):333-9. PubMed ID: 15013147
[TBL] [Abstract][Full Text] [Related]
27. Effect of hydroxypropyl-beta-cyclodextrin-complexation and pH on solubility of camptothecin.
Saetern AM; Nguyen NB; Bauer-Brandl A; Brandl M
Int J Pharm; 2004 Oct; 284(1-2):61-8. PubMed ID: 15454297
[TBL] [Abstract][Full Text] [Related]
28. Improving the solubility of ampelopsin by solid dispersions and inclusion complexes.
Ruan LP; Yu BY; Fu GM; Zhu DN
J Pharm Biomed Anal; 2005 Jul; 38(3):457-64. PubMed ID: 15925247
[TBL] [Abstract][Full Text] [Related]
29. Preparation and solid-state characterization of bupivacaine hydrochloride cyclodextrin complexes aimed for buccal delivery.
Jug M; Maestrelli F; Bragagni M; Mura P
J Pharm Biomed Anal; 2010 May; 52(1):9-18. PubMed ID: 20004541
[TBL] [Abstract][Full Text] [Related]
30. Physicochemical characterization and dissolution properties of nimesulide-cyclodextrin binary systems.
Nalluri BN; Chowdary KP; Murthy KV; Hayman AR; Becket G
AAPS PharmSciTech; 2003; 4(1):E2. PubMed ID: 12916912
[TBL] [Abstract][Full Text] [Related]
31. Cyclodextrins: Efficient biocompatible solubilizing excipients for bromhexine liquid and semi-solid drug delivery systems.
Stojanov M; Nielsen HM; Larsen KL
Int J Pharm; 2012 Jan; 422(1-2):349-55. PubMed ID: 22027391
[TBL] [Abstract][Full Text] [Related]
32. Fosinopril-cyclodextrin inclusion complexes: phase solubility and physicochemical analysis.
Sbârcea L; Udrescu L; Drăgan L; Trandafirescu C; Szabadai Z; Bojiţă M
Pharmazie; 2011 Aug; 66(8):584-9. PubMed ID: 21901980
[TBL] [Abstract][Full Text] [Related]
33. Solid dispersion of hydroxypropyl beta-cyclodextrin and ketorolac: enhancement of in-vitro dissolution rates, improvement in anti-inflammatory activity and reduction in ulcerogenicity in rats.
Nagarsenker MS; Meshram RN; Ramprakash G
J Pharm Pharmacol; 2000 Aug; 52(8):949-56. PubMed ID: 11007065
[TBL] [Abstract][Full Text] [Related]
34. Effect of the solid-dispersion method on the solubility and crystalline property of tacrolimus.
Joe JH; Lee WM; Park YJ; Joe KH; Oh DH; Seo YG; Woo JS; Yong CS; Choi HG
Int J Pharm; 2010 Aug; 395(1-2):161-6. PubMed ID: 20580799
[TBL] [Abstract][Full Text] [Related]
35. Formulation and biological evaluation of glimepiride-cyclodextrin-polymer systems.
Ammar HO; Salama HA; Ghorab M; Mahmoud AA
Int J Pharm; 2006 Feb; 309(1-2):129-38. PubMed ID: 16377107
[TBL] [Abstract][Full Text] [Related]
36. Effect of cyclodextrins on the solubility and antimycotic activity of sertaconazole: experimental and computational studies.
Perdomo-López I; Rodríguez-Pérez AI; Yzquierdo-Peiró JM; White A; Estrada EG; Villa TG; Torres-Labandeira JJ
J Pharm Sci; 2002 Nov; 91(11):2408-15. PubMed ID: 12379926
[TBL] [Abstract][Full Text] [Related]
37. Enhancement of dissolution and oral bioavailability of gliquidone with hydroxy propyl-beta-cyclodextrin.
Sridevi S; Chauhan AS; Chalasani KB; Jain AK; Diwan PV
Pharmazie; 2003 Nov; 58(11):807-10. PubMed ID: 14664337
[TBL] [Abstract][Full Text] [Related]
38. Preparation and characterization of mosapride citrate inclusion complexes with natural and synthetic cyclodextrins.
Ali AA; Sayed OM
Pharm Dev Technol; 2013; 18(5):1042-50. PubMed ID: 22206481
[TBL] [Abstract][Full Text] [Related]
39. Release Characteristics of an Essential Oil Component Encapsulated with Cyclodextrin Shell Matrices.
Li Z; Wen W; Chen X; Zhu L; Cheng G; Liao Z; Huang H; Ming L
Curr Drug Deliv; 2021; 18(4):487-499. PubMed ID: 32735520
[TBL] [Abstract][Full Text] [Related]
40. Investigation of Cyclodextrin-Based Nanosponges for Solubility and Bioavailability Enhancement of Rilpivirine.
Rao MRP; Chaudhari J; Trotta F; Caldera F
AAPS PharmSciTech; 2018 Jul; 19(5):2358-2369. PubMed ID: 29869305
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]